Curriculum Vitae

Asterios Karagiannis

Professor, School of Medicine

Personal Information

- 2310992845
astkar@auth.gr
Scopus IDs7004900413, 57150493800, 55156388300
PubMed IDKaragiannis +A
Γνωστικό Αντικείμενο:
ΠΑΘΟΛΟΓΙΑ
Επιστημονική Ειδίκευση:
- Ιατρική
- Ιατρική διαγνωστική και τεχνολογία θεραπείας

Education

Προπτυχιακές Σπουδές

1977	ΠΤΥΧΙΟ ΙΑΤΡΙΚΗΣ ΙΑΤΡΙΚΗ ΣΧΟΛΗ ΑΡΙΣΤΟΤΕΛΕΙΟ ΠΑΝΕΠΙΣΤΗΜΙΟ ΘΕΣΣΑΛΟΝΙΚΗΣ Greece ΕΙΔΙΚΟΣ ΠΑΘΟΛΟΓΟΣ

Διδακτορικό Δίπλωμα

1988	ΔΔ ΙΑΤΡΙΚΗ ΣΧΟΛΗ ΑΡΙΣΤΟΤΕΛΕΙΟ ΠΑΝΕΠΙΣΤΗΜΙΟ ΘΕΣΣΑΛΟΝΙΚΗΣ Greece

Μετεκπαίδευση

Τμήμα Αρτηριακής Υπέρτασης και Τμήμα Κλινικής Φαρμακολογίας του Πανεπιστημιακού Νοσοκομείου της Λωζάνης, Ελβετία (Centre Hospitalier Universitaire Vaudois, CHUV)με υποτροφία από το Διεθνή Οργανισμό Ατομικής Ενέργειας (International Atomic Energy Agency) όλο το έτος 1995.

Course Work

Courses of Winter semester of 2018–19 academic year

	TMĪMA IATRIKĪS
IA0366	Introduction to Pathological Physiology
ΙΑ0319	Internal Medicine
ΙΑ0321	Internal Medicine II

	TMĪMA ODONTIATRIKĪS
100	Internal Medicine
100602C	Pathology I

	PROGRAMMA METAPTYCΗIAKŌN SPOUDŌN "EREUNĪTIKĪ METHODOLOGIA STĪN IATRIKĪ KAI STIS EPISTĪMES YGEIAS"
ΙΜΓ084	Methodology of the diagnostic and therapeutic approach of the high cardiovascular risk patient

	DIIDRYMATIKO PROGRAMMA METAPTYCΗIAKŌN SPOUDŌN "KRITIKĪ SKEPSĪ KAI ĪPIES DEXIOTĪTES (SOFT SKILLS) STIS VIOÏATRIKES EPISTĪMES"
ΙΜΚΣΒ00008

Courses of Spring semester of 2018–19 academic year

	TMĪMA IATRIKĪS
ΙΑ0319	Internal Medicine
ΙΑ0320	Internal Medicine I

	TMĪMA ODONTIATRIKĪS
100	Internal Medicine
100602C	Pathology I

	DIIDRYMATIKO PROGRAMMA METAPTYCΗIAKŌN SPOUDŌN "KRITIKĪ SKEPSĪ KAI ĪPIES DEXIOTĪTES (SOFT SKILLS) STIS VIOÏATRIKES EPISTĪMES"
ΙΜΚΣΑ0002
ΙΜΚΣΒ0001
ΙΜΣΚΑ0005

Theses Supervised

Student Theses within AUTh

In progress

Griva Theodora. Συσχέτιση παραμέτρων καρδιαγγειακού κινδύνου και αρτηριακής σκληρίας πριν και μετά τη χορήγηση υπολιπιδαιμικής αγωγής σε ασθενείς με σακχαρώδη διαβήτη τύπου 2
Gkotsis Efthymios. Συσχέτιση του βαθμού υιοθέτησης της μεσογειακής διατροφής με το πάχος του έσω-μέσου χιτώνα των κοινών καρωτίδων στο γενικό πληθυσμό
Kollari Erieta. Συσχέτιση των αδιποκινών και μυοκινών του ορού με τη γλυκαιμική ρύθμιση και την εμφάνιση πρώιμης αθηροσκλήρωσης και μακροαγγειοπάθειας σε ασθενείς με σακχαρώδη διαβήτη τύπου 1

2015–2016

Kargiotis Konstantinos. Συσχέτιση της μη αλκοολικής στεατοηπατίτιδας με την αρτηριακή σκληρία, σε ασθενείς με μεταβολικό σύνδρομο πριν και μετά υπολιπιδαιμική αγωγή

2014–2015

Koumaras Charalampos. Σύγκριση των δράσεων της ατενολόλης και των νεώτερων β-αποκλειστικών στις ελαστικές ιδιότητες της αορτής υπερτασικών ασθενών

2013–2014

Grammatikī Maria. Συσχέτιση του πάχους του έσω-μέσου χιτώνα των κοινών καρωτίδων και μηριαίων αρτηριών με το μεταβολικό σύνδρομο
Kollarī Erieta. Συσχέτιση του πάχους του έσω-μέσου χιτώνα της κοινής καρωτίδας και μηριαίας αρτηρίας με το στάδιο της διαβητικής νεφροπάθειας

2009–2010

Kouzoukidou Eirīnī. Διερεύνηση της αρτηριακής σκληρίας ως ανεξάρτητου προγνωστικού παράγοντα κινδύνου σε ασθενείς με ισχαιμικό εγκεφαλικό επεισόδιο

Administrative Work

Τμήματος
#	Από	Έως	Θέση Όργανο / Επιτροπή
1	2011	2013	Director, Β΄ ΠΡΟΠΑΙΔΕΥΤΙΚΗ ΠΑΘΟΛΟΓΙΚΗ ΚΛΙΝΙΚΗ ΑΠΘ

Research Projects

2018–2018	Αναγόρευση του κ. Βασίλειου Παπαλόη σε επίτιμο διδάκτορα του Τμήματος Ιατρικής
2018–2018	Τελετή Αναγόρευσης Επίτιμου Διδάκτορα του Τμήματος Ιατρικής του Γεώργιου Βέλμαχου
2018–2018	Συνέδριο: "4o ABCSE Εραρμοσμένο Βασικ΄πο Κλινικό Σεμινάριο με Σενάρια για φοιτητές"
2018–2018	Συνέδριο: "7ο Επιστημονικό Συνέδριο Τμήματος Ιατρικής"
2017–2018	Έρευνα στο πεδίο του σακχαρώδη διαβήτη
2017–2025	ΔΠΜΣ: "Κριτική σκέψη και ήπιες δεξιότητες (soft skills) στις βιοϊατρικές επιστήμες"
2017–2025	ΔΠΜΣ: "Κριτική σκέψη και ήπιες δεξιότητες (soft skills) στις βιοϊατρικές επιστήμες"
2017–2017	Χρηματοδότηση από ΠΔΕ ΥΠΕΠΘ 2017 - Τμήμα "ΙΑΤΡΙΚΗΣ" ΑΠΘ
2017–2017	Έκδοση ιατρικού συγγράμματος με τίτλο: "Θέματα εσωτερικής Παθολογίας"
2017–2019	Εκπαιδευτικό έργο της Β' Προπαιδευτικής Παθολογικής Κλινικής ΑΠΘ
2016–2022	ΠΜΣ : "Αναπτυξιακή ψυχοπαθολογία βρεφικής και νηπιακής ηλικίας"
2016–2024	Πρόγραμμα Μεταπτυχιακών Σπουδών "Κλινική και χειρουργική ανατομία (Εφαρμοσμένη ανατομία)"
2016–2018	Μελέτη της επίδρασης της δαπαγλιφλοζίνης στην περιπατητική αορτική πίεση, την αρτηριακή σκληρία και τη λευκωματινουρία σε ασθενείς με σακχαρώδη διαβήτη τύπου 2
2016–2023	ΠΜΣ : "Κλινική και Βιομηχανική Φαρμακολογία"
2016–2016	Συνέδριο: "2ο κλινικό Σεμινάριο προσομοίωσης κλινικών περιστατικών για φοιτητές"
2015–2023	ΠΜΣ "Τεχνικές εξωσωματικής κυκλοφορίας - Τεχνολογία συσκευών καρδιοχειρουργικής"
2015–2023	ΠΜΣ "Ιατρική Ερευνητική Μεθοδολογία"
2015–2016	Μια διπλά-τυφλή, τυχαιοποιημένη, ελεγχόμενη με εικονικό φάρμακο κλινική μελέτη φάσεως IV της αποτελεσματικότηατς και της ασφάλειας μιας νέας ενδοφλέβιας φαρμακοτεχνικής μορφής της παρακεταμόλης για την αντιμετώπιση το πυρετού σε ασθενείς με λοιμώξεις
2015–2015	Συνέδριο: "1ο ABCS3 Εφαρμοσμένο κλινικό σεμινάριο για φοιτητές"
2014–2019	Ενίσχυση των ερευνητικών και εκπαιδευτικών υποδομών και δραστηριοτήτων του Τμήματος Ιατρικής -2014-2015-2016-2017
2013–2014	EMERALD: Προοπτική, μη παρεμβατική μελέτη για την καταγραφή της συμμόρφωσης και της ανοχής του έτοιμου συνδυασμού Περινδοπρίλης/Αμλοδιπίνης, στην καθημερινή κλινική πράξη
2011–2019	Διαγνωστική και Θεραπευτική προσέγγιση ασθενών με καρδιαγγειακά νοσήματα
2011–2018	Ερευνητικό έργο της Β' Προπαιδευτικής Παθολογικής Κλινικής ΑΠΘ

Publications

2017

Journal Article

Athyros Vasileios, Alexandrides Theodore K, Bilianou Helen, Cholongitas Evangelos, Doumas Michail, Ganotakis Emmanuel S, Goudevenos John, Elisaf Moses S, Germanidis Georgios, Giouleme Olga, Karagiannis Asterios, et al (2017). The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement. Metabolism. vol.71 p.17-32.
Imprialos Konstantinos P, Boutari Chrysoula, Stavropoulos Konstantinos, Doumas Michail, Karagiannis Asterios (2017). Stroke paradox with SGLT-2 inhibitors: a play of chance or a viscosity-mediated reality?. Journal of Neurology, Neurosurgery & Psychiatry. vol.88 no.3 p.249-253.

2016

Journal Article

Boutari Chrysoula, Stavropoulos Konstantinos, Imprialos Konstantinos, Doumas Michail, Karagiannis Asterios (2016). PATHWAY-2: spironolactone for resistant hypertension, Correspondence. The Lancet. vol.387 no.10026 p.1371-1372.
Katsiki Niki, Kollari Erietta, Dardas Sotirios, Dardas Petros, Haidich Anna-Bettina, Athyros Vasileios, Karagiannis Asterios (2016). Is There an Association Between Carotid-Femoral Pulse Wave Velocity and Coronary Heart Disease in Patients with Coronary Artery Disease: A Pilot Study. The Open Cardiovascular Medicine Journal. vol.10 no.1 p.64-68.
Pantelidis Panteleimon, Staikoglou Nikolaos, Paparoidamis Georgios, Drosos Christos, Karamaroudis Stefanos, Samara Athina, Keskinis Christodoulos, Sideris Michail, Giannakoulas Georgios, Tsoulfas Georgios, Karagiannis Asterios (2016). Medical students' satisfaction with the Applied Basic Clinical Seminar with Scenarios for Students, a novel simulation-based learning method in Greece. Journal of Educational Evaluation for Health Professions. vol.13 p.13.
Romiopoulos Iordanis, Pyrpasopoulou Athina, Varouktsi Anna, Simoulidou Elisavet, Kontopoulou Konstantina, Karantani Ekaterini, Georgopoulou Vivian, Kitsios Konstantinos, Mamopoulos Apostolos, Antachopoulos Charalampos, Karagiannis Asterios, et al (2016). A Rare Case of Disseminated Pyogenic Gonococcal Infection in an Immunocompetent Woman. Case Reports in Infectious Diseases. vol.2016 p.1-4.
Κολλάρη Ε, Γραμματίκη Μ, Σαμπάνη Ε, Τσέπης Κ, Μπουτάρη Χ, Ιμπριάλος Κ, Ζωτράφου Ι, Λεκάκης Β, Σαμπάνης Χ, Καραγιάννης Αστέριος (2016). Συσχέτιση του πάχους του έσω-μέσου χιτώνα των κοινών καρωτίδων και μηριαίων αρτηριών με το στάδιο της διαβητικής νεφροπάθειας. Ελληνικά Διαβητολογικά Χρονικά. vol.29 no.2 p.107-116.

2015

Journal Article

Athyros Vasileios, Tziomalos Konstantinos, Karagiannis Asterios, Mikhailidis Dimitri P (2015). Genetic, epidemiologic and clinical data strongly suggest that fasting or non-fasting triglycerides are independent cardiovascular risk factors. Current Medical Research and Opinion. vol.31 no.3 p.435-438.
Athyros Vasileios, Katsiki Niki, Karagiannis Asterios, Mikhailidis Dimitri P (2015). Short-, mid-, and long-term benefits of peri-procedural high-intensity statin administration in patients undergoing percutaneous coronary intervention. Current Medical Research & Opinion. vol.31 no.2 p.191-195.

2014

Journal Article

Anagnostis Panagiotis, Vakalopoulou Sofia, Vyzantiadis Timoleon-Achilleas, Charizopoulou M, Karras Spiros, Goulis Dimitrios, Karagiannis Asterios, Gerou Spyridon, Garypidou-Vratskidou Vasileia (2014). The clinical utility of bone turnover markers in the evaluation of bone disease in patients with haemophilia A and B. Haemophilia. Vol.20 no.2 p.268-275.
Katsiki Niki, Athyros Vasileios, Karagiannis Asterios (2014). Achieving lipid targets in primary care settings. Current Medical Research and Opinion. vol.30 no.10 p.1971-1974.
Theocharidou E, Gossios T.D, Griva T, Giouleme Olga, Douma Stella, Athyros Vasileios, Karagiannis Asterios (2014). Is there an association between inflammatory bowel diseases and carotid intima-media thickness? Preliminary data. Angiology. Vol.65 no.6 p.543-550.

2013

Journal Article

Anagnostis Panagiotis, Vyzantiadis Timoleon-Achilleas, Charizopoulou M, Adamidou F, Karras S, Goulis Dimitrios, Karagiannis Asterios, Garipidou V, Vakalopoulou Sofia (2013). The effect of monthly Ibandronate on bone mineral density and bone turnover markers in patients with hemophilia A or B and increased risk for fracture. Endocrine Abstracts. vol.32 p.P92.
Anagnostis Panagiotis, Vyzantiadis Timoleon-Achilleas, Charizopoulou M, Adamidou F, Karras S, Goulis Dimitrios, Karagiannis Asterios, Garypidou-Vratskidou Vasileia, Vakalopoulou Sofia (2013). The effect of monthly ibandronate on bone mineral density and bone turnover markers in patients with haemophilia A and B and increased risk for fracture. Thromb Haemost. no.110 p.257-263.
Athyros Vasileios, Katsiki Niki, Tziomalos Konstantinos, Gossios Thomas D, Theocharidou Eleni, Gkaliagkousi Evgenia, Anagnostis Panagiotis, Pagourelias Efstathios D, Karagiannis Asterios, Mikhailidis Dimitri P (2013). Statins and cardiovascular outcomes in elderly and younger patients with coronary artery disease: a post hoc analysis of the GREACE study. Archives of Medical Science. vol.3 p.418-426.

2011

Journal Article

Anagnostis P, Athyros Vasileios, Karagiannis Asterios, Mikhailidis D. P (2011). Impact of statins on glucose metabolism--a matter of debate. The American Journal of Cardiology. vol.107 no.12 p.1866.
Anagnostis P, Athyros Vasileios, Adamidou F, Panagiotou A, Kita M, Karagiannis Asterios, Mikhailidis D. P (2011). Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control. Diabetes, Obesity and Metabolism. vol.13 no.4 p.302-312.
Athyros Vasileios, Tziomalos Konstantinos, Karagiannis Asterios, Mikhailidis D. P (2011). Dyslipidaemia of obesity, metabolic syndrome and type 2 diabetes mellitus: the case for residual risk reduction after statin treatment. The open cardiovascular medicine journal. vol.5 p.24-34.
Athyros Vasileios, Tziomalos Konstantinos, Karagiannis Asterios, Mikhailidis D. P (2011). Cardiovascular benefits of bariatric surgery in morbidly obese patients. Obesity Reviews. vol.12 no.7 p.515-524.
Athyros Vasileios, Katsiki N, Tziomalos Konstantinos, Karagiannis Asterios (2011). Preventing Cardio-renal Syndrome Rather than Treating It: Could Statins Play A Role?. The Open Cardiovascular Medicine Journal. vol.5 p.226-230.
Athyros Vasileios, Karagiannis Asterios, Ganotakis E. S, Paletas Konstantinos, Nicolaou V, Bacharoudis G, Tziomalos Konstantinos, Alexandridis Alexandros-Konstantinos, Liberopoulos E. N, Mikhailidis D. P (2011). Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study. Current Medical Research and Opinion. vol.27 no.8 p.1659-1668.
Athyros Vasileios, Kakafika A. I, Papageorgiou Athanasios, Tziomalos Konstantinos, Peletidou A, Vosikis C, Karagiannis Asterios, Mikhailidis D. P (2011). Effect of a plant stanol ester-containing spread, placebo spread, or Mediterranean diet on estimated cardiovascular risk and lipid, inflammatory and haemostatic factors. Nutrition, Metabolism and Cardiovascular Diseases. vol.21 no.3 p.213-221.
Athyros Vasileios, Chatzitolios Apostolos, Karagiannis Asterios, Savvopoulos Christos, Katsiki N, Tziomalos Konstantinos, Papagianni Aikaterini, Kakafika A, Gossios T. D, Mikhailidis D. P (2011). IMproving the imPlemEntation of cuRrent guidelines for the mAnagement of major coronary hearT disease rIsk factors by multifactorial interVEntion. The IMPERATIVE renal analysis. Archives of Medical Science. vol.7 no.6 p.984-992.
Athyros Vasileios, Gossios T. D, Tziomalos Konstantinos, Florentin M, Karagiannis Asterios, Mikhailidis D. P (2011). Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment?. Archives of Medical Science. vol.7 no.6 p.1067-1075.
Athyros Vasileios, Giouleme Olga, Ganotakis Emmanuel S, Elisaf Moses, Tziomalos Konstantinos, Vasileiadis Themistoklis, Liberopoulos Evangelos N, Theocharidou Eleni, Karagiannis Asterios, Mikhailidis Dimitri P (2011). Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study. Archives of Medical Science. vol.7 no.5 p.796-805.
Katsiki N, Mikhailidis D. P, Athyros Vasileios, Karagiannis Asterios (2011). Alanine aminotransferase is associated with metabolic syndrome independently of insulin resistance. Circulation Journal. vol.75 no.8 p.2027; author reply 2028.
Katsiki N, Athyros Vasileios, Karagiannis Asterios, Mikhailidis D. P (2011). Vitamin D deficiency, statin-related myopathy and other links with vascular risk. Current Medical Research and Opinion. vol.27 no.9 p.1691-1692.
Katsiki N, Athyros Vasileios, Karagiannis Asterios, Mikhailidis D. P (2011). Hyperuricaemia and non-alcoholic fatty liver disease (NAFLD): a relationship with implications for vascular risk?. Current Vascular Pharmacology. vol.9 no.6 p.698-705.
Katsiki N, Athyros Vasileios, Karagiannis Asterios, Mikhailidis D. P (2011). Ezetimibe and low density lipoprotein subfractions: an ongoing debate. Current Medical Research and Opinion. vol.27 no.3 p.693-695.
Katsiki N, Athyros Vasileios, Karagiannis Asterios, Mikhailidis D. P (2011). Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia. International Angiology. vol.30 no.3 p.295; author reply 296.
Katsiki N, Athyros Vasileios, Karagiannis Asterios, Mikhailidis D. P (2011). Current treatment for nonalcoholic fatty liver disease. Expert Opinion on Pharmacotherapy. vol.12 no.13 p.2141-2; author reply 2142.
Pagourelias E. D, Zorou P. G, Tsaligopoulos Miltiadis, Athyros Vasileios, Karagiannis Asterios, Efthymiadis Georgios (2011). Carbon dioxide balneotherapy and cardiovascular disease. International Journal of Biometeorology. vol.55 no.5 p.657-663.
Pagourelias E. D, Gossios T. D, Tziomalos Konstantinos, Karagiannis Asterios, Gkeleris Paraschos, Athyros Vasileios (2011). Residual cardiac risk reduction beyond lipid lowering. Hellenic J Cardiol. vol.52 no.3 p.197-203.
Stavrinou E, Koumaras C, Gossios T. D, Tziomalos Konstantinos, Athyros Vasileios, Karagiannis Asterios (2011). Atherosclerotic renal artery stenosis: an update on diagnosis and management. Current Vascular Pharmacology. vol.9 no.4 p.465-470.
Tziomalos Konstantinos, Athyros Vasileios, Karagiannis Asterios, Mikhailidis D. P (2011). Dyslipidemia induced by drugs used for the prevention and treatment of vascular diseases. The Open Cardiovascular Medicine Journal. vol.5 p.85-89.

2010

Journal Article

Anagnostis P, Karagiannis Asterios, Tziomalos Konstantinos, Athyros Vasileios, Kita M, Mikhailidis D. P (2010). Endocrine hypertension: diagnosis and management of a complex clinical entity. Current Vascular Pharmacology. vol.8 no.5 p.646-660.
Anagnostis P, Athyros Vasileios, Adamidou F, Florentin M, Karagiannis Asterios (2010). Vitamin D and cardiovascular disease: a novel agent for reducing cardiovascular risk?. Current Vascular Pharmacology. vol.8 no.5 p.720-730.
Athyros Vasileios, Tziomalos Konstantinos, Karagiannis Asterios, Wierzbicki A. S, Mikhailidis D. P (2010). Aggressive statin treatment, very low serum cholesterol levels and haemorrhagic stroke: is there an association?. Current Opinion in Cardiology. vol.25 no.4 p.406-410.
Athyros Vasileios, Tziomalos Konstantinos, Karagiannis Asterios, Mikhailidis D. P (2010). To switch (statins) or not to switch? That is the question. Expert Opinion on Pharmacotherapy. vol.11 no.18 p.2943-2946.
Athyros Vasileios, Tziomalos Konstantinos, Karagiannis Asterios, Mikhailidis D. P (2010). Statin-fibrate combination for mixed dyslipidaemia: a limited option?. Current Medical Research and Opinion. vol.26 no.9 p.2137-2140.
Athyros Vasileios, Tziomalos Konstantinos, Karagiannis Asterios, Mikhailidis D. P (2010). Preventing type 2 diabetes mellitus: room for residual risk reduction after lifestyle changes?. Current Pharmaceutical Design. vol.16 no.34 p.3939-3847.
Athyros Vasileios, Tziomalos Konstantinos, Karagiannis Asterios, Mikhailidis D. P (2010). Lipid-lowering agents and new onset diabetes mellitus. Expert Opinion on Pharmacotherapy. vol.11 no.12 p.1965-1970.
Athyros Vasileios, Tziomalos Konstantinos, Karagiannis Asterios, Mikhailidis D. P (2010). Atorvastatin: safety and tolerability. Expert Opinion on Drug Safety. vol.9 no.4 p.667-674.
Athyros Vasileios, Tziomalos Konstantinos, Karagiannis Asterios, Anagnostis P, Mikhailidis D. P (2010). Should adipokines be considered in the choice of the treatment of obesity-related health problems?. Current Drug Targets. vol.11 no.1 p.122-135.
Athyros Vasileios, Tziomalos Konstantinos, Gossios T. D, Griva T, Anagnostis P, Kargiotis K, Pagourelias E. D, Theocharidou E, Karagiannis Asterios, Mikhailidis D. P (2010). Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis. Lancet. vol.376 no.9756 p.1916-1922.
Athyros Vasileios, Tziomalos Konstantinos, Florentin M, Karagiannis Asterios, Mikhailidis D. P (2010). Statin loading in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a new pleiotropic effect?. Current Medical Research and Opinion. vol.26 no.4 p.839-842.
Athyros Vasileios, Mitsiou E. K, Tziomalos Konstantinos, Karagiannis Asterios, Mikhailidis D. P (2010). Impact of managing atherogenic dyslipidemia on cardiovascular outcome across different stages of diabetic nephropathy. Expert Opinion on Pharmacotherapy. vol.11 no.5 p.723-730.
Athyros Vasileios, Mitsiou E. K, Tziomalos Konstantinos, Karagiannis Asterios, Mikhailidis D. P (2010). Concurrent blood pressure, glycemic and lipid control for the prevention of vascular complications of type II diabetes mellitus: a long overdue objective?. Current Vascular Pharmacology. vol.8 no.1 p.1-4.
Athyros Vasileios, Karagiannis Asterios, Mikhailidis D. P (2010). Statins and heart failure. Journal of the American College of Cardiology. vol.55 no.15 p.1644-5; author reply 1646.
Athyros Vasileios, Ganotakis E. S, Tziomalos Konstantinos, Papageorgiou Athanasios, Anagnostis P, Griva T, Kargiotis K, Mitsiou E. K, Karagiannis Asterios, Mikhailidis D. P (2010). Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population. Current Medical Research and Opinion. vol.26 no.3 p.713-719.
Chimonas T, Karagiannis Asterios, Athyros Vasileios, Achimastos A, Elisaf M, Panagiotakos D. B (2010). Blood pressure levels constitute the most important determinant of the metabolic syndrome in a Mediterranean population: a discrimination analysis. Metabolic Syndrome and Related Disorders. vol.8 no.6 p.523-529.
Karagiannis Asterios, Tziomalos Konstantinos, Pagourelias E. D, Gossios T. D, Athyros Vasileios (2010). Effect of antihypertensive drug-associated diabetes on cardiovascular risk. Hellenic Journal of Cardiology. vol.51 no.3 p.195-199.
Karagiannis Asterios, Tziomalos Konstantinos, Mikhailidis D. P, Semertzidis P, Kountana E, Kakafika A. I, Pagourelias E. D, Athyros Vasileios (2010). Seasonal variation in the occurrence of stroke in Northern Greece: a 10 year study in 8204 patients. Neurological Research. vol.32 no.3 p.326-331.
Karagiannis Asterios, Tziomalos Konstantinos, Anagnostis P, Gossios T. D, Florentin M, Athyros Vasileios, Mikhailidis D. P (2010). The effect of antihypertensive agents on insulin sensitivity, lipids and haemostasis. Current Vascular Pharmacology. vol.8 no.6 p.792-803.
Katsiki N, Mikhailidis D. P, Athyros Vasileios, Chatzitolios Apostolos, Karagiannis Asterios, Banach M (2010). Are we getting to lipid targets in real life?. Archives of Medical Science. vol.6 no.5 p.639-641.
Koumaras C, Anagnostis P, Tzimou M, Giavanidis I, Gossios T, Antoniadis Antonios, Athyros Vasileios, Karagiannis Asterios (2010). Paraganglioma in a young patient with asymptomatic severe hypertension: a case report and review of the literature. Hippokratia. vol.14 no.4 p.300-302.
Pagourelias E. D, Giannoglou Georgios, Kouidi Evangelia, Efthymiadis Georgios, Zorou P, Tziomalos Konstantinos, Karagiannis Asterios, Athyros Vasileios, Gkeleris Paraschos, Mikhailidis D. P (2010). Brain natriuretic peptide and the athlete’s heart: a pilot study. International journal of clinical practice. Wiley Online Library. vol.64 no.4 p.511-517.
Pagourelias Efstathios D, Giannoglou Georgios, Kouidi Evangelia, Efthymiadis Georgios, Zorou P, Tziomalos Konstantinos, Karagiannis Asterios, Athyros Vasileios, Gkeleris Paraschos, Mikhailidis D. P (2010). Brain natriuretic peptide and the athletes heart: a pilot study. International Journal of Clinical Practice. vol.64 no.4 p.511-517.
Tziomalos Konstantinos, Athyros Vasileios, Karagiannis Asterios, Mikhailidis D. P (2010). The role of ankle brachial index and carotid intima-media thickness in vascular risk stratification. Current Opinion in Cardiology. vol.25 no.4 p.394-398.
Tziomalos Konstantinos, Athyros Vasileios, Karagiannis Asterios, Mikhailidis D. P (2010). Management of statin-intolerant high-risk patients. Current Vascular Pharmacology. vol.8 no.5 p.632-637.
Tziomalos Konstantinos, Athyros Vasileios, Karagiannis Asterios, Mikhailidis D. P (2010). Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management. Nutrition, Metabolism and Cardiovascular Diseases. vol.20 no.2 p.140-146.
Παγκουρέλιας Ε, Κουϊδή Ευαγγελία, Κουμαράς Χ, Γιαννόγλου Γεώργιος, Ευθυμιάδης Γεώργιος, Ζώρου Π, Άθυρος Βασίλειος, Καραγιάννης Αστέριος, Δεληγιάννης Αστέριος, Γκελερής Παράσχος (2010). Διάκριση της αθλητικής καρδιάς από την υπερτροφική μυοκαρδιοπάθειας. Ελληνική Επιθεώρηση Αθηροσκλήρωσης. vol.2 no.2 p.112-120.

2009

Journal Article

Anagnostis P, Karagiannis Asterios, Tziomalos Konstantinos, Kakafika A. I, Athyros Vasileios, Mikhailidis D. P (2009). Adrenal incidentaloma: a diagnostic challenge. Hormones (Athens). vol.8 no.3 p.163-184.
Anagnostis P, Karagiannis Asterios, Kakafika A. I, Tziomalos Konstantinos, Athyros Vasileios, Mikhailidis D. P (2009). Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities?. Osteoporosis International. vol.20 no.2 p.197-207.
Anagnostis P, Athyros Vasileios, Tziomalos Konstantinos, Karagiannis Asterios, Mikhailidis D. P (2009). Clinical review: The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. The Journal of Clinical Endocrinology & Metabolism. vol.94 no.8 p.2692-2701.
Athyros Vasileios, Tziomalos Konstantinos, Karagiannis Asterios, Mikhailidis D. P (2009). Statins and cardiovascular events in patients with end-stage renal disease on hemodialysis. The AURORA results suggest the need for earlier intervention. Curr Vasc Pharmacol. vol.7 no.3 p.264-266.
Athyros Vasileios, Tziomalos Konstantinos, Karagiannis Asterios, Mikhailidis D. P (2009). The JUPITER trial results boost the evidence for the use of hsCRP as a treatment target and as part of the assessment of vascular risk: time for new guidelines?. Hellenic Journal of Cardiology. vol.50 no.2 p.89-91.
Athyros Vasileios, Karagiannis Asterios, Chatzitolios Apostolos, Paletas Konstantinos, Savvopoulos Christos, Giannoglou Georgios, Mikhailidis D. P (2009). Standardized arrangement for a guideline-driven treatment of the metabolic syndrome: the SAGE-METS study. Current Medical Research and Opinion. vol.25 no.4 p.971-980.
Athyros Vasileios, Kakafika A. I, Wierzbicki A. S, Karagiannis Asterios, Mikhailidis D. P (2009). Targeting triglycerides in secondary prevention: should we bother?. The International Journal of Clinical Practicea. vol.63 no.1 p.15-18.
Athyros Vasileios, Kakafika A. I, Tziomalos Konstantinos, Karagiannis Asterios, Mikhailidis D. P (2009). Pleiotropic effects of statins--clinical evidence. Current Pharmaceutical Design. vol.15 no.5 p.479-489.
Athyros Vasileios, Chatzitolios Apostolos, Karagiannis Asterios, Didangelos Triantafyllos, Iliadis Fotios, Dolgyras S, Vosnakidis T, Vasiliadis P, Malias I, Samouilidou M, Mikhailidis D. P (2009). Initiative for a new diabetes therapeutic approach in a Mediterranean country: the INDEED study. Current Medical Research and Opinion. vol.25 no.8 p.1931-1940.
Chatzitolios Apostolos, Athyros Vasileios, Karagiannis Asterios, Savvopoulos Christos, Charalambous C, Kyriakidis G, Milidis T, Papathanakis C, Bitli A, Vogiatsis I, Ntaios G, et al (2009). Implementation of strategy for the management of overt dyslipidemia: the IMPROVE-dyslipidemia study. International Journal of Cardiology. vol.134 no.3 p.322-329.
Karagiannis Asterios, Tziomalos Konstantinos, Anagnostis P, Gossios T, Athyros Vasileios (2009). Atherosclerotic renal artery stenosis: medical therapy alone or in combination with revascularization?. Angiology. vol.60 no.4 p.397-402.
Karagiannis Asterios, Chatzitolios Apostolos, Athyros Vasileios, Deligianni K, Charalambous C, Papathanakis C, Theodosiou G, Drakidis T, Chatzikaloudi V, Kamilali C, Matsiras S, et al (2009). Implementation of guidelines for the management of arterial hypertension. The impulsion study. The Open Cardiovascular Medicine Journal. vol.3 p.26-34.
Karagiannis Asterios, Athyros Vasileios, Mikhailidis D. P (2009). A comparison of the aldosterone-blocking agents eplerenone and spironolactone. Clinical Cardiology. vol.32 no.4 p.230.
Koletsi D, Karagianni A, Pandis N, Makou M, Polychronopoulou A, Eliades T (2009). Are studies reporting significant results more likely to be published?. American Journal of Orthodontics and Dentofacial Orthopedics. vol.136 no.5.
Mitsiou E. K, Tziomalos Konstantinos, Anagnostis P, Karagiannis Asterios, Athyros Vasileios (2009). Multifactorial intervention for the prevention of vascular complications of type 2 diabetes. Hellenic Journal of Cardiology. vol.50 no.6 p.445-448.
Pagourelias E. D, Papageorgiou Athanasios, Basayannis E, Athyros Vasileios, Karagiannis Asterios, Zorou P, Gkeleris Paraschos (2009). Severe exertional dyspnea as the prime manifestation of acute cytomegalovirus infection in an immunocompetent adult. Hippokratia. vol.13 no.3 p.181-183.
Pagourelias E. D, Koumaras C, Kakafika A. I, Tziomalos Konstantinos, Zorou P. G, Athyros Vasileios (2009). Cardiorenal anemia syndrome: do erythropoietin and iron therapy have a place in the treatment of heart failure?. Angiology. vol.60 no.1 p.74-81.
Tziomalos Konstantinos, Kakafika A. I, Athyros Vasileios, Karagiannis Asterios, Mikhailidis D. P (2009). The role of statins for the primary and secondary prevention of coronary heart disease in women. Current Pharmaceutical Design. vol.15 no.10 p.1054-1062.
Tziomalos Konstantinos, Athyros Vasileios, Karagiannis Asterios, Mikhailidis D. P (2009). JUPITER: major implications for vascular risk assessment. Current Medical Research and Opinion. vol.25 no.1 p.133-137.
Tziomalos Konstantinos, Athyros Vasileios, Karagiannis Asterios, Mikhailidis D. P (2009). Dyslipidemia as a risk factor for ischemic stroke. Current Topics in Medicinal Chemistry. vol.9 no.14 p.1291-1297.
Tziomalos Konstantinos, Athyros Vasileios, Karagiannis Asterios, Mikhailidis D. P (2009). Anti-inflammatory effects of fibrates: an overview. Current Medicinal Chemistry. vol.16 no.6 p.676-684.
Tziomalos Konstantinos, Athyros Vasileios, Karagiannis Asterios, Kolovou G. D, Mikhailidis D. P (2009). Triglycerides and vascular risk: insights from epidemiological data and interventional studies. Current Drug Targets. vol.10 no.4 p.320-327.

2008

Journal Article

Anagnostis P, Stangou M, Leontsini M, Athyros Vasileios, Karagiannis Asterios (2008). Unusual manifestation of diarrhea-associated haemolytic uraemic syndrome in an adult. Renal Failure. vol.30 no.3 p.331-334.
Athyros Vasileios, Tziomalos Konstantinos, Karagiannis Asterios, Mikhailidis D. P (2008). Preventing macrovascular complications of diabetes: where do we stand with glycemic control?. Expert Opinion on Investigational Drugs. vol.17 no.12 p.1777-1779.
Athyros Vasileios, Tziomalos Konstantinos, Kakafika A. I, Koumaras H, Karagiannis Asterios, Mikhailidis D. P (2008). Effectiveness of ezetimibe alone or in combination with twice a week Atorvastatin (10 mg) for statin intolerant high-risk patients. The American Journal of Cardiology. vol.101 no.4 p.483-485.
Athyros Vasileios, Kakafika A. I, Tziomalos Konstantinos, Papageorgiou Athanasios, Karagiannis Asterios (2008). Statins for the prevention of first or recurrent stroke. Current Vascular Pharmacology. vol.6 no.2 p.124-133.
Athyros Vasileios, Kakafika A. I, Tziomalos Konstantinos, Karagiannis Asterios, Mikhailidis D. P (2008). CORONA, statins, and heart failure: who lost the crown?. Angiology. vol.59 no.1 p.5-8.
Athyros Vasileios, Kakafika A. I, Tziomalos Konstantinos, Karagiannis Asterios, Mikhailidis D. P (2008). Antisense technology for the prevention or the treatment of cardiovascular disease: the next blockbuster?. Expert Opinion on Investigational Drugs. vol.17 no.7 p.969-972.
Athyros Vasileios, Kakafika A. I, Papageorgiou Athanasios, Paraskevas K. I, Tziomalos Konstantinos, Anagnostis P, Pagourelias E, Koumaras C, Karagiannis Asterios, Mikhailidis D. P (2008). Effects of statin treatment in men and women with stable coronary heart disease: a subgroup analysis of the GREACE Study. Current Medical Research and Opinion. vol.24 no.6 p.1593-1599.
Athyros Vasileios, Kakafika A. I, Karagiannis Asterios, Mikhailidis D. P (2008). Do we need to consider inflammatory markers when we treat atherosclerotic disease?. Atherosclerosis. vol.200 no.1 p.1-12.
Athyros Vasileios, Kakafika A. I, Karagiannis Asterios, Koragiannis A, Mikhailidis D. P, Mikhalidis D. P (2008). Effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in patients with diabetes mellitus and mixed dyslipidemia. The American Journal of Cardiology. vol.101 no.11 p.1679-1680.
Athyros Vasileios, Kakafika A, Tziomalos Konstantinos, Karagiannis Asterios, Mikhailidis D. P (2008). Cholesteryl ester transfer protein inhibition and HDL increase: has the dream ended?. Expert Opinion on Investigational Drugs. vol.17 no.4 p.445-449.
Kakafika A, Athyros Vasileios, Tziomalos Konstantinos, Karagiannis Asterios, Mikhailidis D. P (2008). High density lipoprotein cholesterol and statin trials. Current Medicinal Chemistry. vol.15 no.22 p.2265-2270.
Kakafika A. I, Athyros Vasileios, Tziomalos Konstantinos, Karagiannis Asterios, Mikhailidis D. P (2008). Primary and secondary coronary heart disease prevention using statins: is targeting Adam or Eve equally effective?. Expert Opinion on Pharmacotherapy. vol.9 no.9 p.1437-1440.
Karagiannis Asterios, Tziomalos Konstantinos, Papageorgiou Athanasios, Kakafika A. I, Pagourelias E. D, Anagnostis P, Athyros Vasileios, Mikhailidis D. P (2008). Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism. Expert Opinion on Pharmacotherapy. vol.9 no.4 p.509-515.
Karagiannis Asterios, Tziomalos Konstantinos, Kakafika A. I, Athyros Vasileios, Mikhailidis D. P (2008). Medical treatment as an alternative to adrenalectomy in patients with aldosterone-producing adenomas. Endocrine-Related Cancer. vol.15 no.3 p.693-700.
Karagiannis Asterios, Mikhailidis D. P, Tziomalos Konstantinos, Kakafika A. I, Athyros Vasileios (2008). Editorial [ Has the Time Come for a New Definition of Microalbuminuria? ]. Current Vascular Pharmacology. vol.6 no.2 p.81-83.
Sampanis C, Tziomalos Konstantinos, Kountana E, Kakavas N, Zografou I, Balaska A, Koulas G, Karagiannis Asterios, Zampoulis Chrysanthos (2008). Effect of pioglitazone on heart function and N-terminal pro-brain natriuretic peptide levels of patients with type 2 diabetes. Acta Diabetologica. vol.45 no.1 p.23-30.
Tziomalos Konstantinos, Athyros Vasileios, Karagiannis Asterios, Mikhailidis D. P (2008). Omega-3 fatty acids: how can they be used in secondary prevention?. Current Atherosclerosis Reports. vol.10 no.6 p.510-517.
Tziomalos Konstantinos, Athyros Vasileios, Karagiannis Asterios, Mikhailidis D. P (2008). Established and emerging vascular risk factors and the development of aortic stenosis: an opportunity for prevention?. Expert Opinion on Therapeutic Targets. vol.12 no.7 p.809-820.

2007

Journal Article

Athyros V. G, Kakafika A, Karagiannis A, Mikhailidis D. P (2007). Statins and regression of coronary atherosclerosis. JAMA. vol.297 no.20 p.2197; author reply 2197.
Athyros Vasileios, Tziomalos Konstantinos, Mikhailidis D. P, Pagourelias E. D, Kakafika A. I, Skaperdas A, Chatzitolios Apostolos, Karagiannis Asterios (2007). Do we need a statin-nicotinic acid-aspirin mini-polypill to treat combined hyperlipidaemia?. Expert Opinion on Pharmacotherapy. vol.8 no.14 p.2267-2277.
Athyros Vasileios, Mikhailidis D. P, Liberopoulos E. N, Kakafika A. I, Karagiannis Asterios, Papageorgiou Athanasios, Tziomalos Konstantinos, Ganotakis E. S, Elisaf M (2007). Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study. Nephrology Dialysis Transplantation. vol.22 no.1 p.118-127.
Athyros Vasileios, Mikhailidis D. P, Kakafika A. I, Tziomalos Konstantinos, Karagiannis Asterios (2007). Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?. Expert Opinion on Pharmacotherapy. vol.8 no.5 p.529-535.
Athyros Vasileios, Mikhailidis D. P, Kakafika A. I, Karagiannis Asterios, Chatzitolios Apostolos, Tziomalos Konstantinos, Ganotakis E. S, Liberopoulos E. N, Elisaf M (2007). Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levels. Current Drug Targets. vol.8 no.3 p.483-488.
Athyros Vasileios, Liberopoulos E. N, Mikhailidis D. P, Papageorgiou Athanasios, Ganotakis E. S, Tziomalos Konstantinos, Kakafika A. I, Karagiannis Asterios, Lambropoulos S, Elisaf M (2007). Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort. Angiology. vol.58 no.6 p.689-697.
Athyros Vasileios, Karagiannis Asterios, Liberopoulos E. N, Elisaf M, Mikhailidis D. P (2007). Statin treatment may be beneficial to both the kidneys and the heart. Peritoneal Dialysis International. vol.27 no.2 p.215-216.
Athyros Vasileios, Karagiannis Asterios, Kakafika A, Elisaf M, Mikhailidis D. P (2007). Statins and renal function. Is the compound and dose making a difference?. Nephrology Dialysis Transplantation. vol.22 no.3 p.963-4; author reply 964.
Athyros Vasileios, Kakafika A. I, Papageorgiou Athanasios, Tziomalos Konstantinos, Skaperdas A, Pagourelias E, Pirpasopoulou A, Karagiannis Asterios, Mikhailidis D. P (2007). Atorvastatin decreases triacylglycerol-associated risk of vascular events in coronary heart disease patients. Lipids. vol.42 no.11 p.999-1009.
Athyros Vasileios, Kakafika A. I, Papageorgiou Athanasios, Pagourelias E. D, Savvatianos S. D, Elisaf M, Karagiannis Asterios, Tziomalos Konstantinos, Mikhailidis D. P (2007). Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients. The Open Cardiovascular Medicine Journal. vol.1 p.8-14.
Athyros Vasileios, Ganotakis E. S, Elisaf M. S, Liberopoulos E. N, Goudevenos I. A (2007). Prevalence of vascular disease in metabolic syndrome using three proposed definitions. International Journal of Cardiology. vol.117 no.2 p.204-210.
Kakafika A. I, Mikhailidis D. P, Wierzbicki A. S, Karagiannis Asterios, Athyros Vasileios (2007). PCI and stable coronary heart disease--COURAGE to change our minds?. Current Vascular Pharmacology. vol.5 no.3 p.173-174.
Kakafika A. I, Mikhailidis D. P, Karagiannis Asterios, Athyros Vasileios (2007). The role of endocannabinoid system blockade in the treatment of the metabolic syndrome. The Journal of Clinical Pharmacology. vol.47 no.5 p.642-652.
Karagiannis Asterios, Tziomalos Konstantinos, Kakafika A, Florentin M, Athyros Vasileios (2007). Eplerenone relieves spironolactone-induced painful gynaecomastia in a patient with primary aldosteronism. Nephrology Dialysis Transplantation. vol.22 no.1 p.293.
Karagiannis Asterios, Tziomalos Konstantinos, Athyros Vasileios (2007). Is angioedema a class adverse effect of the angiotensin-converting enzyme inhibitors?. Ann Allergy Asthma Immunol. vol.98 no.5 p.502.
Karagiannis Asterios, Mikhailidis D. P, Tziomalos Konstantinos, Sileli M, Savvatianos S, Kakafika A, Gossios T, Krikis N, Moschou I, Xochellis M, Athyros Vasileios (2007). Serum uric acid as an independent predictor of early death after acute stroke. Clinical Investigation. vol.71 no.7 p.1120-1127.
Karagiannis Asterios, Mikhailidis D. P, Kakafika A. I, Tziomalos Konstantinos, Athyros Vasileios (2007). Atenolol: differences in mode of action compared with other antihypertensives. An opportunity to identify features that influence outcome?. Current Pharmaceutical Design. vol.13 no.2 p.229-239.
Karagiannis Asterios, Mikhailidis D. P, Athyros Vasileios, Kakafika A. I, Tziomalos Konstantinos, Liberopoulos E. N, Florentin M, Elisaf M (2007). The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?. Expert Opinion on Therapeutic Targets. vol.11 no.2 p.191-205.
Karagiannis Asterios, Mikhailidis D. P, Athyros Vasileios, Charsoulis Faidon (2007). Pheochromocytoma: an update on genetics and management. Endocr Relat Cancer. vol.14 no.4 p.935-956.
Paraskevas Kosmas I, Athyros Vasileios, Briana Despina D, Kakafika Anna I, Karagiannis Asterios, Mikhailidis Dimitri P (2007). Statins exert multiple beneficial effects on patients undergoing percutaneous revascularization procedures. Current Drug Targets. vol.8 no.8 p.942-951.
Pyrpasopoulou A, Athyros Vasileios, Karagiannis Asterios, Chrysomallis Fotios, Zampoulis Chrysanthos (2007). Intravenous immunoglobulins: a valuable asset in the treatment of a case of septic febrile ulceronecrotic Mucha-Habermann disease. Dermatology. vol.215 no.2 p.164-165.
Tziomalos Konstantinos, Florentin M, Krikis N, Perifanis Vasileios, Karagiannis Asterios, Charsoulis Faidon (2007). Persistent effect of zoledronic acid in Paget's disease. Clinical and Experimental Rheumatology. vol.25 no.3 p.464-466.
Tziomalos Konstantinos, Athyros Vasileios, Karagiannis Asterios, Mikhailidis D. P (2007). Endothelial function, arterial stiffness and lipid lowering drugs. Expert Opinion on Therapeutic Targets. vol.11 no.9 p.1143-1160.
Tziomalos Konstantinos, Perifanis Vasileios, Karagiannis Asterios, Krikis N, Semertzidis P, Diakou Anastasia, Garypidou-Vratskidou Vasileia, Charsoulis Faidon (2007). Diagnosing and treating visceral leishmaniasis in 3 patients in Greece. Infections in medicine. vol.24 no.5 p.220-223.

Conference Proceedings Article

Καραγιάννης Α, Λάμπου Ε, Καραρίζος Π. Β (2007). Μετατόπιση του ξύλου με ελκυστήρες και καταπόνηση των δασικών εδαφών. 5o Πανελλήνιο Συνέδριο Γεωργικής Μηχανικής. Λάρισα. vol.5 p.568-774.

2006

Journal Article

Vyzantiadis Timoleon-Achilleas, Karagiannis Asterios, Douma Stella, Charsoulis Faidon, Vyzantiadis Athanasios, Zampoulis Chrysanthos (2006). Vascular Endothelial Growth Factor and Nitric Oxide Serum Levels in Arterial Hypertension. Clinical and Experimental Hypertension. Vol.28 no.7 p.603-609.

Conference Proceedings Article

Karagiannis E. A, Kararizos P. B, Karagiannis A (2006). Application of modern automated machines in forest opening-up works. International conference on eco-engineering «The use of vegetation in improve slope stability». p.87.
Karagiannis E. A, Kararizos P. B, Karagiannis A (2006). Application of modern automated machines in forest opening-up works. International Conference“Sustainable Management and Development of Mountainous and Island Areas". 29th September-1st October 2006, Island of Naxos, Greece. vol.2 p.241-246.

2003

Journal Article

Alexiou M, Dendrinou-Samara C, Karagianni A, Biswas S, Zaleski C. M, Kampf J, Penner-Hahn J, Pecoraro V. L, Kessissoglou D. P (2003). Models for the lower S states of Photosystem II: A trinuclear mixed-valent MnII/ MnIV/ MnII complex. Inorg.Chem. vol.42 p.2185-2187.

2001

Journal Article

Καραγιάννης Αστέριος, Μπαλάσκα Κ, Τοκαλάκη-Νικολαϊδου Λ, Δημητριάδου Δ, Παπαγεωργίου Α, Σωτηρόπουλος Μ, Βυζαντιάδης Τιμολέων - Αχιλλέας, Ζαμπούλης Χρύσανθος (2001). Η σχέση του πολυμορφισμού του γονιδίου του μετατρεπτικού ενζύμου της αγγειοτενσίνης Ι και του ισχαιμικού εγκεφαλικού εμφράκτου. Ελληνική Ιατρική. vol.67 no.1 p.51-56.

1999

Journal Article

Dimopoulos M.A, Bakoyannis C, Georgoulias V, Papadimitriou C, Moulopoulos L.A, Deliveliotis C, Karagiannis Asterios, Varkarakis I, Aravantinos G, Anagnostopoulos A, Giannopoulos Andreas, et al (1999). Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: A multicenter phase II study of the Hellenic Cooperative Oncology Group. Annals of Oncology. Published Version. vol.10 no.11 p.1385-1388.

1996

Journal Article

Vassilikioti S, Doumas Michail, Douma Stella, Petidis Konstantinos, Karagiannis Asterios, Balaska K, Vyzantiadis Athanasios, Zampoulis Chrysanthos (1996). Angiotensin converting enzyme gene polymorphism is not related to essential hypertension in a Greek population. American Journal of Hypertension. Vol.9 no.7 p.700–702.

1995

Journal Article

Karagiannis Asterios, Douma Stella, Athyros Vasileios, Vizantiadis A, Voujiouklis N, Zafiriades E, Efremidis S, Zampoulis Chrysanthos (1995). Percutaneous transluminal renal angioplasty in patients with renovascular hypertension: long-term results. Hypertension Research. Vol.18 no.1 p.27-31.

1994

Journal Article

Karagiannis Asterios, Douma Stella, Vogiatzis K, Petidis Konstantinos, Doumas Michail, Vyzantiadis Athanasios, Efremidis S, Zampoulis Chrysanthos (1994). The relationship between the sympathetic nervous system and the renin-angiotensin system in renovascular hypertension. Acta Cardiologica. Vol.49 no.5 p.425-434.

1992

Journal Article

Douma Stella, Zampoulis Chrysanthos, Karagiannis Asterios, Sinakos Zacharias (1992). Effects of adrenaline infusion on serum thromboxane B2 and plasma beta-thromboglobulin levels in hypertensive and normotensive subjects. Nouvelle Revue Française d'Hématologie.

1989

Journal Article

Zampoulis Chrysanthos, Karagiannis Asterios, Douma Stella, Vogiatzis K, Doumas Michail, Byzantiades A, Metaxas P, Efremidis S (1989). Changes of Plasma Noradrenaline Levels in the Renal and Systemic Circulation After Successful Percutaneous Transluminal Angioplasty in Renovascular Hypertension. Clinical and Experimental Hypertension. Part A: Theory and Practice. vol.11 no.sup1 p.449-458.

1983

Journal Article

Deligiannis Asterios, Vargemezis Vassilios, Tsobanelis H, Karagiannis Asterios, Kontopoulos Athanasios (1983). The acute effect of peritoneal dialysis fluid on left ventricular function in patients on CAPD. Life Support Systems. vol.1 suppl.1 p.179-182.

Updated: 2018-10-20

Quality Assurance Unit (MODIP)
Aristotle University of Thessaloniki

You are here

Curriculum Vitae

Asterios Karagiannis

Προπτυχιακές Σπουδές

Διδακτορικό Δίπλωμα

Μετεκπαίδευση

Courses of Winter semester of 2018–19 academic year

Courses of Spring semester of 2018–19 academic year

Student Theses within AUTh

In progress

2015–2016

2014–2015

2013–2014

2009–2010

Journal Article

Journal Article

Journal Article

Journal Article

Journal Article

Journal Article

Journal Article

Journal Article

Journal Article

Journal Article

Conference Proceedings Article

Journal Article

Conference Proceedings Article

Journal Article

Journal Article

Journal Article

Journal Article

Journal Article

Journal Article

Journal Article

Journal Article

Journal Article

Quality Assurance Unit (MODIP)Aristotle University of Thessaloniki

You are here

Curriculum Vitae

Asterios Karagiannis

Προπτυχιακές Σπουδές

Διδακτορικό Δίπλωμα

Μετεκπαίδευση

Courses of Winter semester of 2018–19 academic year

Courses of Spring semester of 2018–19 academic year

Student Theses within AUTh

In progress

2015–2016

2014–2015

2013–2014

2009–2010

Journal Article

Journal Article

Journal Article

Journal Article

Journal Article

Journal Article

Journal Article

Journal Article

Journal Article

Journal Article

Conference Proceedings Article

Journal Article

Conference Proceedings Article

Journal Article

Journal Article

Journal Article

Journal Article

Journal Article

Journal Article

Journal Article

Journal Article

Journal Article

Quality Assurance Unit (MODIP)
Aristotle University of Thessaloniki